Here’s how Oxitec’s GMO mosquitoes might help limit the scourge of malaria

Credit: Oxitec
Credit: Oxitec

Last year, Oxitec released tens of thousands of GM mosquitoes in Djibouti, where there has been a resurgence of malaria caused by an invasive species. It was the first time such mosquitoes have been released in east Africa and the second time on the continent.

The impact of these mosquitoes on malaria transmission could be significant, believes Lottie Renwick, head of strategy for Malaria No More UK. “They will play a really major role and be gamechanging,” she says, but adds that the intervention needs to work alongside other tools such as mosquito nets and injections.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

The lab-produced mosquitoes carry a “self-limiting” gene that blocks normal cellular processes, which means if they mate, any female offspring will die. The male progeny, which do not bite, will survive and go on to mate with other wild females. With sustained releases of these “friendly mosquitoes”, more females die off, greatly reducing the mosquito population and the spread of malaria.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
ChatGPT-Image-May-1-2026-02_20_13-PM
How RFK, Jr.’s false vaccine claims are holding up $600 million to fight diseases in poor countries
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
viva-la-vida-watermelons
Misinformation and climate change are endangering summer watermelons
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
ChatGPT-Image-Mar-27-2026-11_27_05-AM
The myths of “process”: What science says about the “dangers’ of synthetic products and ultra-processed foods
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Drinking lots of water can help reduce the effects of aging
Nanoplastics in drinking water: MAHA activists forge science-based bipartisan coalition 
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
79d03212-2508-45d0-b427-8e9743ff6432
Viewpoint: The Casey Means hustle—Wellness woo opportunism dressed up as medical wisdom
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.